Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. We believe that health and well-being create the foundation for a good life and society.
In 2023 Orion received funding from Business Finland to build a unique ecosystem for data and AI driven transformation of drug discovery. The ecosystem will create new opportunities for Finnish companies and research organizations to co-operate and develop novel services and products for the global healthcare market.